This Solicitation opportunity from Michigan was posted on July 3, 2024. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

Statewide Drug Screen and Confirmation Testing for MDHHS

Closed

240000002120State & Local

Submission Closed08/08/2024, 11:59:00 AM EDT

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 621511

New

SLED

Drug Testing & Laboratory ServicesThis subcontract opportunity with San Diego County in California involves providing comprehensive drug testing and non-drug laboratory services to support prime contractors on healthcare and social services program projects. The selected provider will be responsible for the collection of samples and the execution of laboratory analyses for both clinical tests and drug screenings, ensuring all results and reports are delivered accurately. To qualify for this engagement, the service provider must hold CLIA certification or an equivalent laboratory accreditation to ensure all screening processes meet required standards. Interested parties should note that the response deadline is December 23, 2026, and the work will be performed within San Diego.

POSTED

DEADLINE

Rodent Histopathology and Toxicologic Pathology ServicesThis subcontract for Rodent Histopathology and Toxicologic Pathology Services supports prime contractors on Environmental Protection Agency projects within the Tribal and Science Division Water. The scope of work involves the processing and evaluation of maternal and neonatal rodent specimen organs to analyze the biological effects of air pollutants, phthalates, PFAS, and endocrine-disrupting compounds. The selected provider must utilize specialized histology equipment for slide preparation and pathology analysis while maintaining strict adherence to GLP regulations and EPA Quality Assurance Program requirements. Key deliverables include the provision of comprehensive histopathology reports and evaluated pathology data.

Tribal & Science Division Water

POSTED

DEADLINE

Semen Analysis (SA) and Post-Vasectomy Semen Analysis (PVSA) Laboratory ServicesThis subcontract opportunity is for the provision of specialized clinical laboratory services, specifically semen analysis and post-vasectomy semen analysis, to support prime contractors on Department of Veterans Affairs VISN 22 projects. The selected provider will be responsible for receiving and processing specimens, performing the required analyses, and delivering validated test reports. To be eligible, the contractor must possess a current Clinical Laboratory Improvement Amendments certificate and maintain facilities specifically equipped for andesmic and semen analysis. Strict adherence to HIPAA privacy regulations is mandatory. This is a total small business set-aside under NAICS code 621511, managed by the Department of Veterans Affairs Network Contract Office 22.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Q301--VISN 22 Semen & Vasectomy Test Kits

Solicitation # 36C26227Q0056-0001

The Department of Veterans Affairs, Network Contracting Office 22, is soliciting a firm-fixed-price contract for specialized referral laboratory services to perform semen analysis and post-vasectomy semen analysis. This comprehensive, end-to-end service requirement includes the provision of at-home collection kits with a minimum six-month shelf life, patient logistics, specimen shipping, laboratory testing, and result reporting via a secure web portal. The contractor must maintain current Clinical Laboratory Improvement Amendments (CLIA) certification and ensure strict compliance with HIPAA and Department of Transportation regulations regarding the handling and transport of biological specimens. Award will be based on the best value to the government, evaluating technical ability to meet the statement of work, price, and transportation and delivery factors. Key performance metrics include a 95% success rate for specimen integrity and timely delivery, and a 90% adherence to test turnaround schedules. The contract is a small business set-aside and is structured for a five-year period consisting of a base period and four option periods. Invoicing is handled monthly through the Contracting Officer, with payments made in accordance with the Prompt Payment Act.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Drug Demand Reduction Program (DDRP)

Solicitation # W50S8227QA002

Solicitation W50S8227QA002 is a total small business set-aside for a fixed-price contract to support the 175th Wing Drug Demand Reduction Program for the Maryland Air National Guard in Middle River, Maryland. The contractor is required to provide all personnel, equipment, and supervision to perform specimen collection, packaging, and on-site observation services in strict accordance with DAFMAN 44-197. Key personnel requirements include the provision of a Drug Testing Program Administrative Manager and Observers, with specific deadlines for submitting appointment letters, training certificates, and signed observer statements. The contract structure consists of a 12-month base period followed by four option years. The government will award the contract to the responsible offeror determined to be most advantageous based on price and other considered factors. Quotes must be submitted via PIEE by November 20, 2026. Awardees must submit a final Quality Control Plan within 15 calendar days of award and designate a contract manager within five calendar days. Invoicing and payment will be processed electronically through Wide Area WorkFlow. Compliance requirements include adherence to SCA WD 2015-4265, cybersecurity reporting under DFARS 252.204-7012, and the mitigation of any organizational conflicts of interest.

W7ND Uspfo Activity Mdang 175

POSTED

DEADLINE

NWI Offsite Pathology Services

Solicitation # 36C26326R0063

The Department of Veterans Affairs, Nebraska-Western Iowa Health Care System, is soliciting a Fixed Price, Indefinite Delivery, Indefinite Quantity (IDIQ) contract for offsite medical laboratory, pathology, and testing analysis services. The selected contractor will be responsible for pre-analytic processing, analysis, and reporting of clinical and anatomical pathology specimens, including the provision of all necessary personnel and specialized collection and transportation supplies. While the VA handles most specimen collection and preparation, the contractor is responsible for grossing global surgical pathology cases and must return all slides and blocks to the VA for permanent storage. The contract features a five-year ordering period beginning April 1, 2027, with a total small business set-aside. Award will be based on the Lowest Priced Technically Acceptable (LPTA) quote, with technical acceptability contingent upon CAP, Joint Commission, and CLIA accreditations, as well as a review of past performance from the previous five years. The contractor must adhere to strict quality standards outlined in the Quality Assurance Surveillance Plan, including a 100 percent accuracy rate for specimen labeling and specific turnaround times for cytology and autopsy reports. Key requirements include compliance with HIPAA, the Privacy Act, and hazardous materials regulations for transporting biological substances. The contractor must also maintain specific insurance coverages, including general liability and employer's liability, and ensure all personnel undergo background investigations per VA security standards.

Network Contract Office 23 (36C263)

POSTED

DEADLINE

Non-DOT Drug Testing Laboratory ServicesThe Massachusetts Bay Transportation Authority is seeking a subcontract for Non-DOT Drug Testing Laboratory Services to support prime contractors on various drug testing projects. The selected provider will be responsible for the analysis and reporting of urine specimens for non-DOT regulated employees and applicants. This includes identifying negative, non-negative, and confirmed positive results, as well as managing outcomes related to dilute, adulterated, substituted, invalid, or cancelled specimens. To qualify for this engagement, the laboratory must maintain CLIA accreditation and be capable of delivering comprehensive laboratory test reports. Interested parties should note that the response deadline is December 8, 2026, and the services fall under NAICS code 621511.

Massachusetts Bay Transportation Authority

POSTED

DEADLINE

DOT Drug Testing Laboratory ServicesThis subcontract for DOT Drug Testing Laboratory Services involves the analysis and reporting of urine specimens for prime contractors working on Massachusetts Bay Transportation Authority drug testing projects. The selected provider will be responsible for determining a wide range of results, including negative, non-negative, confirmed positive, dilute negative, adulterated, substituted, invalid, and cancelled statuses, while performing necessary confirmation testing for all non-negative results. To qualify, the provider must operate a DOT-certified laboratory that strictly adheres to all DOT regulatory standards to ensure the delivery of certified laboratory test results. This opportunity is categorized under NAICS code 621511, with a response deadline set for December 8, 2026.

Massachusetts Bay Transportation Authority

POSTED

DEADLINE

RFP 124-26 Lab Drug Testing

Solicitation # BD-27-1206-40000-40000-135345

The Massachusetts Bay Transportation Authority (MBTA) is soliciting proposals under RFP 124-26 (Solicitation BD-27-1206-40000-40000-135345) for a laboratory to provide DOT and Non-DOT drug testing for employees and applicants. The selected provider must be capable of analyzing a wide range of specimen outcomes and ensuring secure electronic transmission of results to the MBTA Drug Program system. All DOT testing must comply with 49 CFR Part 40 and HHS Mandatory Guidelines, while Non-DOT testing will generally follow the same processes. The scope of work includes managing the end-to-end testing process from courier collection to result transmission to the Medical Review Officer (MRO). The contract will be awarded on a best-value basis, evaluating a combination of technical capability, supplier diversity, and price. Bidders must submit a comprehensive proposal via COMMBUYS, including a technical response covering turnaround times, testing capabilities, system integration, and courier services. The MBTA requires strict adherence to labor laws, anti-discrimination statutes, and human trafficking prohibitions. While the contract does not require performance guarantees, liquidated damages, or specific security requirements, it does mandate compliance with MBTA minimum insurance requirements and specific safety training for personnel working near rail transit lines. Payment is processed through the MBTA invoicing system with a standard review period of fifteen days.

Massachusetts Bay Transportation Authority

POSTED

DEADLINE

Clinical Laboratory Analysis and TestingThis subcontract for Clinical Laboratory Analysis and Testing involves performing laboratory analysis of biological samples to support prime contractors on NIMHD health disparities research projects. The selected provider will be responsible for processing samples and conducting assays using specialized diagnostic equipment and laboratory facilities. All work must be performed in strict accordance with Good Clinical Laboratory Practices (GCLP) to ensure compliance. The primary deliverables for this engagement include the provision of laboratory test results and validated data reports. This opportunity is associated with the National Institutes of Health Olao under the Department of Health and Human Services.

National Institutes Of Health Olao

POSTED

DEADLINE

PHPA 4166: Maryland Volunteer and Professional Firefighters Innovative Cancer Screening Technologies Program

Solicitation # BPM058949

The Maryland Department of Health, Center for Cancer Prevention and Control, is offering grants through the Maryland Volunteer and Professional Firefighters Innovative Cancer Screening Technologies Program (PHPA 4166/BPM058949). This initiative provides funding to local fire departments, volunteer fire companies, and local governments to procure and administer innovative cancer screening tests that are not typically covered by insurance or offered during routine physical examinations. Eligible applicants must be Maryland-based and are required to assemble a healthcare team to select appropriate tests, oversee the screening process, and provide participants with necessary counseling and navigation to diagnostic services. The program has a total funding allocation of 900,000 dollars, which will be distributed among multiple awards on a pro rata basis based on evaluation scores. Technical and financial factors are weighted equally during the selection process, with a preference for tests supported by strong clinical evidence, those utilizing novel technologies, and tests capable of screening for multiple cancer types simultaneously. The performance period for the grants is scheduled from March 1, 2027, to June 30, 2027. Funding is provided on a reimbursement basis, requiring grantees to maintain accurate records and submit invoices and financial reports to the Maryland Department of Health. Applications must be submitted via the eMaryland Marketplace Advantage portal by November 20, 2026.

POSTED

DEADLINE

Biospecimen Logistics and Repository ServicesThe Biospecimen Logistics and Repository Services subcontract, issued by the National Institutes of Health under the Department of Health and Human Services, focuses on the collection, transfer, and storage of biospecimens for research network projects. The selected provider will be responsible for managing physical sample movement and coordinating with national repositories through the use of cold chain logistics and LIMS software. Performance of these services will take place in Bethesda. To ensure safety and quality, the contractor must adhere to CLIA/CAP standards and maintain IATA certification for the handling of hazardous biological materials. The primary objective is the secure transfer and detailed cataloging of biospecimens. Interested parties must respond by November 23, 2026, under NAICS code 621511.

National Institutes Of Health Nichd

POSTED

8 days ago

DEADLINE

in 9 days

General Info

Agency

Michigan → Technology, Management and Budget

NAICS

621511 - Medical Laboratories

Place of Performance

MI, USA

Set-Aside

NONE

Documents

contract-document

High

sow

High

sow

High

sow

High

sow

High

sow

High

contract-document

High

rfp

High

sow

High

pricing-schedule

High

AI Contract Breakdown

Uniform Contract Format

View Full Breakdown

Timeline

PhaseClosed

PostedJul 3

Solicitation

Response DeadlineAug 8

Deadline has passed

Submission Closed

08/08/2024, 11:59:00 AM EDT

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyMichigan → Technology, Management and Budget

Contacts1 person available

OfficeN/A

Organization / AgencyMichigan → Technology, Management and Budget

Office AddressN/A

Contacts

Nichole Harrell

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Get full access

Join 750+ contractors already using CLEATUS

Statewide Drug Screen and Confirmation Testing for MDHHS

Contract Overview

Active Opportunities Like This One

General Info

Documents

AI Contract Breakdown

This one is closed. Find the next one like it.

Ask CLEATUS

Timeline

Find active opportunities like this

Organization & Contact Information

Get AI-powered intelligence on the opportunities still open